You Are Browsing ‘Medical’ Category

Auris Medical Holding AG (NASDAQ:EARS) announced that its CEO, Thomas Meyer, is scheduled to present at an investor event in New York next week. The company is currently involved in a multilayer study of a treatment for inner ear disorders. Enrollment is ongoing for the Phase 3 trial of its lead drug candidate…

Invacare Corporation (NYSE:IVC)’s upbeat fourth-quarter and revenue numbers cheered the investors pushing the stock high in the last trading session….

With the aim to bolster hospital products, Pfizer Inc. (NYSE:PFE) said that it will acquire rival Hospira, Inc. (NYSE:HSP) in a $17 billion deal. The said…

The reason Ardelyx Inc (NASDAQ:ARDX) is printing red is that the drug company discovered an unfavorable development in a mid-stage trial of its highly-publicized…

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) unveiled to the world that it has received due information from sources at Ildong Pharmaceutical Co., Ltd., that…

Onconova Therapeutics Inc (NASDAQ:ONTX)‘s plans for rigosertib lacked conviction as the stock tumbled steeply in the previous session. The company…

Zogenix, Inc. (NASDAQ:ZGNX) won the Food And Drug Administration (FDA) approval for a new formulation its much-debated painkiller Zohydro. Late on Friday…

The question remains unanswered to the validity of bullish report published for Pluristem Therapeutics Inc. (NASDAQ:PSTI) last week, which is the reason…

Ardelyx Inc (NASDAQ:ARDX)‘s day seesawed between the positive results of its experimental drug and the higher side-effects. However, the weight of…

Following a week of huge gains, thinly traded nano-cap stock Genetic Technologies Limited (ADR) (NASDAQ:GENE) has tumbled again. The shares of the company…

SPYR banner1